National Academies Press: OpenBook
« Previous: 5 Accelerating Research and Clinical Translation: Consortia and PublicPrivate Partnerships
Suggested Citation:"Appendix A: References." National Academies of Sciences, Engineering, and Medicine. 2018. Enabling Novel Treatments for Nervous System Disorders by Improving Methods for Traversing the Blood–Brain Barrier: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/25044.
×

A

References

Aryal, M., N. Vykhodtseva, Y. Z. Zhang, J. Park, and N. McDannold. 2013. Multiple treatments with liposomal doxorubicin and ultrasound–induced disruption of blood–tumor and blood–brain barriers improve outcomes in a rat glioma model. Journal of Controlled Release 169(1–2):103–111.

Boado, R. J., and W. M. Pardridge. 2017. Brain and organ uptake in the rhesus monkey in vivo of recombinant iduronidase compared to an insulin receptor antibody-iduronidase fusion protein. Molecular Pharmaceutics 14(4):1271–1277.

Boado, R. J., E. K. Hui, J. Z. Lu, and W. M. Pardridge. 2009. Agt–181: Expression in cho cells and pharmacokinetics, safety, and plasma iduronidase enzyme activity in rhesus monkeys. Journal of Biotechnology 144(2):135–141.

Boado, R. J., E. K. Hui, J. Z. Lu, R. K. Sumbria, and W. M. Pardridge. 2013. Blood–brain barrier molecular Trojan horse enables imaging of brain uptake of radioiodinated recombinant protein in the rhesus monkey. Bioconjugate Chemistry 24(10):1741–1749.

Brynskikh, A. M., Y. Zhao, R. L. Mosley, S. Li, M. D. Boska, N. L. Klyachko, A. V. Kabanov, H. E. Gendelman, and E. V. Batrakova. 2010. Macrophage delivery of therapeutic nanozymes in a murine model of Parkinson’s disease. Nanomedicine 5(3):379–396.

Chan, G. N., R. A. Evans, D. B. Banks, E. V. Mesev, D. S. Miller, and R. E. Cannon. 2017. Selective induction of P-glycoprotein at the CNS barriers during symptomatic stage of an ALS animal model. Neuroscience Letters 639:103–113.

Cho, C. F., J. M. Wolfe, C. M. Fadzen, D. Calligaris, K. Hornburg, E. A. Chiocca, N. Y. R. Agar, B. L. Pentelute, and S. E. Lawler. 2017. Blood–brain barrier spheroids as an in vitro screening platform for brain-penetrating agents. Nature Communications 8:15623.

Deane, R., S. Du Yan, R. K. Submamaryan, B. LaRue, S. Jovanovic, E. Hogg, D. Welch, L. Manness, C. Lin, J. Yu, H. Zhu, J. Ghiso, B. Frangione, A. Stern, A. M. Schmidt, D. L. Armstrong, B. Arnold, B. Liliensiek, P. Nawroth, F.

Suggested Citation:"Appendix A: References." National Academies of Sciences, Engineering, and Medicine. 2018. Enabling Novel Treatments for Nervous System Disorders by Improving Methods for Traversing the Blood–Brain Barrier: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/25044.
×

Hofman, M. Kindy, D. Stern, and B. Zlokovic. 2003. RAGE mediates amyloid-beta peptide transport across the blood–brain barrier and accumulation in brain. Nature Medicine 9(7):907–913.

Deverman, B. E., P. L. Pravdo, B. P. Simpson, S. R. Kumar, K. Y. Chan, A. Banerjee, W. L. Wu, B. Yang, N. Huber, S. P. Pasca, and V. Gradinaru. 2016. CRE-dependent selection yields AAV variants for widespread gene transfer to the adult brain. Nature Biotechnology 34(2):204–209.

Dou, H., C. B. Grotepas, J. M. McMillan, C. J. Destache, M. Chaubal, J. Werling, J. Kipp, B. Rabinow, and H. E. Gendelman. 2009. Macrophage delivery of nanoformulated antiretroviral drug to the brain in a murine model of neuroaids. Journal of Immunology 183(1):661–669.

Foust, K. D., E. Nurre, C. L. Montgomery, A. Hernandez, C. M. Chan, and B. K. Kaspar. 2009. Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes. Nature Biotechnology 27(1):59–65.

Griffin, J. H., B. V. Zlokovic, and L. O. Mosnier. 2015. Activated protein C: Biased for translation. Blood 125(19):2898–2907.

Griffin, J. H., J. A. Fernandez, P. D. Lyden, and B. V. Zlokovic. 2016. Activated protein C promotes neuroprotection: Mechanisms and translation to the clinic. Thrombosis Research 141(Suppl 2):S62–S64.

Haney, M. J., P. Suresh, Y. Zhao, G. D. Kanmogne, I. Kadiu, M. Sokolsky–Papkov, N. L. Klyachko, R. L. Mosley, A. V. Kabanov, H. E. Gendelman, and E. V. Batrakova. 2012. Blood–borne macrophage–neural cell interactions hitchhike on endosome networks for cell–based nanozyme brain delivery. Nanomedicine 7(6):815–833.

Haney, M. J., Y. Zhao, E. B. Harrison, V. Mahajan, S. Ahmed, Z. He, P. Suresh, S. D. Hingtgen, N. L. Klyachko, R. L. Mosley, H. E. Gendelman, A. V. Kabanov, and E. V. Batrakova. 2013. Specific transfection of inflamed brain by macrophages: A new therapeutic strategy for neurodegenerative diseases. PLoS ONE 8(4):e61852.

Hatherell, K., P. O. Couraud, I. A. Romero, B. Weksler, and G. J. Pilkington. 2011. Development of a three-dimensional, all-human in vitro model of the blood–brain barrier using mono-, co-, and tri-cultivation transwell models. Journal of Neuroscience Methods 199(2):223–229.

Ivanova, E., C. W. Yee, and B. T. Sagdullaev. 2016. Leveraging optogeneticbased neurovascular circuit characterization for repair. Neurotherapeutics 13(2):341–347.

Jones, A. R., and E. V. Shusta. 2007. Blood–brain barrier transport of therapeutics via receptor-mediation. Pharmaceutical Research 24(9):1759–1771.

Kaplitt, M. G., A. Feigin, C. Tang, H. L. Fitzsimons, P. Mattis, P. A. Lawlor, R. J. Bland, D. Young, K. Strybing, D. Eidelberg, and M. J. During. 2007. Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson’s disease: An open label, phase I trial. Lancet 369(9579):2097–2105.

Suggested Citation:"Appendix A: References." National Academies of Sciences, Engineering, and Medicine. 2018. Enabling Novel Treatments for Nervous System Disorders by Improving Methods for Traversing the Blood–Brain Barrier: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/25044.
×

Khot, A., J. Tibbitts, D. Rock, and D. K. Shah. 2017. Development of a translational physiologically based pharmacokinetic model for antibody-drug conjugates: A case study with T–DM1. AAPS Journal 19(6):1715–1734.

Lochhead, J. J., D. J. Wolak, M. E. Pizzo, and R. G. Thorne. 2015. Rapid transport within cerebral perivascular spaces underlies widespread tracer distribution in the brain after intranasal administration. Journal of Cerebral Blood Flow & Metabolism 35(3):371–381.

Lockman, P. R., R. K. Mittapalli, K. S. Taskar, V. Rudraraju, B. Gril, K. A. Bohn, C. E. Adkins, A. Roberts, H. R. Thorsheim, J. A. Gaasch, S. Huang, D. Palmieri, P. S. Steeg, and Q. R. Smith. 2010. Heterogeneous blood-tumor barrier permeability determines drug efficacy in experimental brain metastases of breast cancer. Clincal Cancer Research 16(23):5664–5678.

Marty, B., B. Larrat, M. Van Landeghem, C. Robic, P. Robert, M. Port, D. Le Bihan, M. Pernot, M. Tanter, F. Lethimonnier, and S. Meriaux. 2012. Dynamic study of blood–brain barrier closure after its disruption using ultrasound: A quantitative analysis. Journal of Cerebral Blood Flow & Metabolism 32(10):1948–1958.

McDannold, N., C. D. Arvanitis, N. Vykhodtseva, and M. S. Livingstone. 2012. Temporary disruption of the blood–brain barrier by use of ultrasound and microbubbles: Safety and efficacy evaluation in rhesus macaques. Cancer Research 72(14):3652–3663.

Muller, P. Y., M. Milton, P. Lloyd, J. Sims, and F. R. Brennan. 2009. The minimum anticipated biological effect level (MABEL) for selection of first human dose in clinical trials with monoclonal antibodies. Current Opinion in Biotechnology 20(6):722–729.

Neufield, E., and J. Muenzer. 2001. The mucopolysaccharidoses. In The metabolic and molecular bases of inherited disease, edited by C. Scriver, A. Beaudet, D. Valle, and W. Sly. New York: McGraw–Hill Companies. Pp. 3421–3452.

Pardridge, W. M. 2006. Molecular Trojan horses for blood–brain barrier drug delivery. Current Opinion in Pharmacology 6(5):494–500.

Park, J., Y. Zhang, N. Vykhodtseva, F. A. Jolesz, and N. J. McDannold. 2012. The kinetics of blood–brain barrier permeability and targeted doxorubicin delivery into brain induced by focused ultrasound. Journal of Controlled Release 162(1):134–142.

Park, J., M. Aryal, N. Vykhodtseva, Y. Z. Zhang, and N. McDannold. 2017. Evaluation of permeability, doxorubicin delivery, and drug retention in a rat brain tumor model after ultrasound-induced blood–tumor barrier disruption. Journal of Controlled Release 250:77–85.

Shapiro, E. G., I. Nestrasil, K. Rudser, K. Delaney, V. Kovac, A. Ahmed, B. Yund, P. J. Orchard, J. Eisengart, G. R. Niklason, J. Raiman, E. Mamak, M. J. Cowan, M. Bailey–Olson, P. Harmatz, S. P. Shankar, S. Cagle, N. Ali, R. D. Steiner, J. Wozniak, K. O. Lim, and C. B. Whitley. 2015. Neurocognition

Suggested Citation:"Appendix A: References." National Academies of Sciences, Engineering, and Medicine. 2018. Enabling Novel Treatments for Nervous System Disorders by Improving Methods for Traversing the Blood–Brain Barrier: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/25044.
×

across the spectrum of mucopolysaccharidosis type I: Age, severity, and treatment. Molecular Genetics and Metabolism 116(1–2):61–68.

Thorne, R. G., L. R. Hanson, T. M. Ross, D. Tung, and W. H. Frey, 2nd. 2008. Delivery of interferon–beta to the monkey nervous system following intranasal administration. Neuroscience 152(3):785–797.

Whiteman, D. A., and A. Kimura. 2017. Development of idursulfase therapy for mucopolysaccharidosis type II (Hunter syndrome): The past, the present and the future. Drug Design, Development and Therapy 11:2467–2480.

Winkler, E. A., Y. Nishida, A. P. Sagare, S. V. Rege, R. D. Bell, D. Perlmutter, J. D. Sengillo, S. Hillman, P. Kong, A. R. Nelson, J. S. Sullivan, Z. Zhao, H. J. Meiselman, R. B. Wendy, J. Soto, E. D. Abel, J. Makshanoff, E. Zuniga, D. C. De Vivo, and B. V. Zlokovic. 2015. GLUT1 reductions exacerbate Alzheimer’s disease vasculo–neuronal dysfunction and degeneration. Nature Neuroscience 18(4):521–530.

Yuan, D., Y. Zhao, W. A. Banks, K. M. Bullock, M. Haney, E. Batrakova, and A. V. Kabanov. 2017. Macrophage exosomes as natural nanocarriers for protein delivery to inflamed brain. Biomaterials 142:1–12.

Zhao, Y., M. J. Haney, N. L. Klyachko, S. Li, S. L. Booth, S. M. Higginbotham, J. Jones, M. C. Zimmerman, R. L. Mosley, A. V. Kabanov, H. E. Gendelman, and E. V. Batrakova. 2011. Polyelectrolyte complex optimization for macrophage delivery of redox enzyme nanoparticles. Nanomedicine 6(1):25–42.

Zhao, Y., M. J. Haney, R. Gupta, J. P. Bohnsack, Z. He, A. V. Kabanov, and E. V. Batrakova. 2014. GDNF–transfected macrophages produce potent neuroprotective effects in Parkinson’s disease mouse model. PLoS ONE 9(9):e106867.

Zhao, Z., A. R. Nelson, C. Betsholtz, and B. V. Zlokovic. 2015. Establishment and dysfunction of the blood–brain barrier. Cell 163(5):1064–1078.

Zlokovic, B. V. 2011. Neurovascular pathways to neurodegeneration in Alzheimer’s disease and other disorders. Nature Review Neuroscience 12(12):723–738.

Suggested Citation:"Appendix A: References." National Academies of Sciences, Engineering, and Medicine. 2018. Enabling Novel Treatments for Nervous System Disorders by Improving Methods for Traversing the Blood–Brain Barrier: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/25044.
×
Page 41
Suggested Citation:"Appendix A: References." National Academies of Sciences, Engineering, and Medicine. 2018. Enabling Novel Treatments for Nervous System Disorders by Improving Methods for Traversing the Blood–Brain Barrier: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/25044.
×
Page 42
Suggested Citation:"Appendix A: References." National Academies of Sciences, Engineering, and Medicine. 2018. Enabling Novel Treatments for Nervous System Disorders by Improving Methods for Traversing the Blood–Brain Barrier: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/25044.
×
Page 43
Suggested Citation:"Appendix A: References." National Academies of Sciences, Engineering, and Medicine. 2018. Enabling Novel Treatments for Nervous System Disorders by Improving Methods for Traversing the Blood–Brain Barrier: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/25044.
×
Page 44
Next: Appendix B: Workshop Agenda »
Enabling Novel Treatments for Nervous System Disorders by Improving Methods for Traversing the Blood–Brain Barrier: Proceedings of a Workshop Get This Book
×
Buy Paperback | $55.00 Buy Ebook | $44.99
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

Despite substantial advances in developing treatments for the serious illnesses that affect people worldwide, there remains a tremendous unmet need in the treatment of complex neurologic diseases, including neuropsychiatric and neurodegenerative disorders. Chief among the challenges that have hindered the development of therapeutics for central nervous system (CNS) disorders is the blood–brain barrier (BBB). The Forum on Neuroscience and Nervous System Disorders of the National Academies of Sciences, Engineering, and Medicine convened a workshop to explore the challenges associated with the BBB that have thus far stymied development of CNS drugs, examine new technologies that could address these challenges, and highlight potential opportunities for moving the field forward. This publication summarizes the presentations and discussions from the workshop.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!